Announcement of providing guarantee for the holding company
Release time:
2020-08-05
Securities Abbreviations: Jianfeng Group Securities Code: 600668 Number: Pro 2019-010
Bond Abbreviations: 13 Peak 02 Bond Code: 122344
Announcement of Zhejiang Jianfeng Group Co., Ltd.
Providing Guarantee for Holding Subsidiaries
The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and assumes individual and joint responsibility for the truthfulness, accuracy and completeness of its contents .
Important Content Tips
● Names of Guarantees: Zhejiang Jianfeng Pharmaceutical Co., Ltd., Shanghai Beika Pharmaceutical Technology Co., Ltd. and its wholly-owned subsidiaries, Guizhou Huangpinggu Longmingchuan Cement Co., Ltd., Zhejiang Jianfeng International Trade Co., Ltd.
● To set up a financing guarantee amount: Set up a financing guarantee amount 8.8 .3 billion yuan.
● Is there any counter-guarantee in this guarantee: No
● Cumulative quantity of overdue external guarantee: No
Overview of 1. guarantee
2019 4 26 , zhejiang Jianfeng Group Co., Ltd. held thethnd meeting of the 10th Board of Directors. The company currently has nine directors, eight of whom attended the meeting in person. Director Du Zihong entrusted Director Jiang Xiaomeng to attend the meeting on his behalf and vote , complies with the relevant provisions of the "Company Law" and the company's "Articles of Association", and the resolutions made are legal and valid. The meeting was presided over by Chairman Jiang Xiaomeng. After deliberation and voting, the "Proposal on Providing Guarantees to Holding Subsidiaries" was deliberated and passed with 9 votes in favor, 0 votes against, and 0 abstentions.
The motion needs to be submitted to the shareholders' meeting for consideration.
Basic Information of Guaranteed 2.
1 , Zhejiang Jianfeng Pharmaceutical Co., Ltd. (hereinafter referred to as "Jianfeng Pharmaceutical"), registered capital 19853 Yuan, of which: the company accounts for 99.16% , registered address: on the second floor of No. 87 X02 office quality inspection building, No. 85 58 , Gaofan Section, Baitang Downline, Wucheng District, Jinhua City, Zhejiang Province, is mainly engaged in drug research and development and production (operated with valid licenses); Import raw and auxiliary materials for production and scientific research; Imported mechanical equipment, instruments and spare parts.
, Shanghai Beika Medical Technology Co., Ltd. (hereinafter referred to as "Shanghai Beika"), with a registered capital of 2275.93 yuan, of which: the company accounts for 61.48% , registered address: Building 99 21 , 3802 , Shengang Road, Songjiang District, Shanghai, mainly engaged in: technology development, technical consultation, technical service and technology transfer in the field of medicine and chemistry; wholesale and retail of mechanical equipment, instruments and meters, edible agricultural products (excluding pig products), chemical fertilizers, feed additives, chemical raw materials and products (except dangerous goods); development and sales of pharmaceutical intermediates; import and export of goods and technologies. Shanghai Beika has three wholly-owned subsidiaries: Anhui Xinbeika Chemical Co., Ltd., Anhui Jianfeng Beika Pharmaceutical Co., Ltd., and Anhui Zhongwang Pharmaceutical Co., Ltd. 3
5000 .06 million yuan, the company accounts for 100% , registered address: Gulong Industrial Park, Huangping County, Qiandongnan Miao and Dong Autonomous Prefecture, Guizhou Province, mainly engaged in research and development, production and sales of cement products and process equipment; ordinary Portland cement and commercial concrete, cement products, limestone, artificial sand, gravel, aggregate manufacturing sales. 4
3000 .14 million yuan, of which: the company accounts for 93.33% , Jianfeng Pharmaceutical accounts for 6.67 , registered address: No. 88 , No. 119, changchun West Road, Jindong Economic Development Zone, Zhejiang, mainly engaged in: import and export of goods and technologies permitted by national laws and regulations without pre-approval; road cargo transportation; road transport station (field) operation; food management; sales of pharmaceutical intermediates, pharmaceutical equipment, etc. and online sales; national laws and policies permit Business consulting service activities; carry out international transportation agency business for import and export goods, and general cargo storage services. 3. of the above subsidiaries 2018
financial data (unit: ten thousand yuan)
|
# total 144 liabilities
|
total current liabilities
|
total bank loans
|
net assets
|
Total Operating Income
|
Net Profit Attributed to Owners of Parent Company
|
| Peak Pharmaceutical
144410.77
|
94187.16
|
88383.69
|
4600
|
50223.61
|
148762.44
|
3696.70
|
| Shanghai North Carolina
24853.30
|
10729.36
|
10685.21
|
3700
|
14123.94
|
21469.79
|
-90.77
|
| Peak International Trade
13677.85
|
11564.77
|
11462.27
|
|
2113.08 |
14443.11
|
567.82
|
| Mingchuan, Guizhou
6955.58
|
7633.27
|
7633.27
|
|
-677.70 |
0
|
-240.56
|
|
, the guarantee provided by the holding subsidiary to borrow money from financial institutions, set the following limits:
Limit (RMB 10,000)
|
| Zhejiang Jianfeng Pharmaceutical Co., Ltd.
30000
|
| Shanghai Beika Pharmaceutical technology Co., Ltd. and its wholly-owned subsidiary
20000
|
| Guizhou Huangpinggu Longmingchuan Cement Co., Ltd.
30000
|
| Zhejiang Jianfeng International Trade Co., Ltd.
8000
|
|
More information
Company fully deploys 2019 work
On January 28, the group company held a business analysis meeting to review and summarize the work situation in 2018, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises made reports on the overall work situation in 2018, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2019. Xiang Chongping, deputy general manager of the group company, made a systematic review of the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the internal control, safety and environmental protection work in 2018. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2018 and made a comparative analysis of the main economic indicators of each industrial sector. In 2018, the operating indicators of the company's various industrial sectors have improved significantly year-on-year, and the group company has also created the best operating performance in history. All units have completed the formulation of the second round of "three-year business plan", which points out the direction for the next three years of business work; the group company has also completed the first draft of the new "five-year strategic development plan", which is being revised and enriched. In addition, the two main businesses have also made substantial progress in investment expansion and industrial integration around strategic objectives, and the operating costs of major enterprises have decreased to varying degrees; the optimization of organizational structure and post setting has achieved new results, and management efficiency and people
2020
07-22
Company fully deploys 2019 work
On January 28, the group company held a business analysis meeting to review and summarize the work situation in 2018, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises made reports on the overall work situation in 2018, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2019. Xiang Chongping, deputy general manager of the group company, made a systematic review of the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the internal control, safety and environmental protection work in 2018. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2018 and made a comparative analysis of the main economic indicators of each industrial sector. In 2018, the operating indicators of the company's various industrial sectors have improved significantly year-on-year, and the group company has also created the best operating performance in history. All units have completed the formulation of the second round of "three-year business plan", which points out the direction for the next three years of business work; the group company has also completed the first draft of the new "five-year strategic development plan", which is being revised and enriched. In addition, the two main businesses have also made substantial progress in investment expansion and industrial integration around strategic objectives, and the operating costs of major enterprises have decreased to varying degrees; the optimization of organizational structure and post setting has achieved new results, and management efficiency and people
2020
07-31
The truth about private equity investments you need to know.
China Securities Regulatory Commission Zhejiang Regulatory Bureau and China Securities Investor Protection Fund Co., Ltd. jointly launched the "those private equity fund investment truth you need to know" investment education products. With the outbreak of private equity investment, the proportion of individual investors has further increased, and there are more and more "rich myth" scams. But the things behind "private placement" may not be as simple as you think, and risk prevention knowledge needs to be known early.
2020
07-31
The truth about private equity investments you need to know.
China Securities Regulatory Commission Zhejiang Regulatory Bureau and China Securities Investor Protection Fund Co., Ltd. jointly launched the "those private equity fund investment truth you need to know" investment education products. With the outbreak of private equity investment, the proportion of individual investors has further increased, and there are more and more "rich myth" scams. But the things behind "private placement" may not be as simple as you think, and risk prevention knowledge needs to be known early.
2020
07-30
The truth about private equity investments you need to know.
China Securities Regulatory Commission Zhejiang Regulatory Bureau and China Securities Investor Protection Fund Co., Ltd. jointly launched the "those private equity fund investment truth you need to know" investment education products. With the outbreak of private equity investment, the proportion of individual investors has further increased, and there are more and more "rich myth" scams. But the things behind "private placement" may not be as simple as you think, and risk prevention knowledge needs to be known early.
2020
07-31
Chairman Jiang Xiaomeng Directs Work in Yunnan Peak
On December 16, Jiang Xiaomeng, Secretary of the Party committee and chairman of the group company, went to Yunnan Jianfeng cement company to investigate and guide the work. On the morning of the same day, accompanied by the Yunnan peak management team, Jiang Xiaomeng went deep into the front line and successively went to the central control room of the production and manufacturing department, the raw material clay yard, the lignite yard and other areas for field investigation and investigation to understand the problems existing in the production and operation process. Subsequently, a business analysis meeting was held to make a comparative analysis of the various business indicators of Yunnan Jianfeng from January to November this year, and put forward two requirements to the management team: further strengthen internal management and improve execution; strengthen the coordination of external relations, and improve The ability and level of enterprise resource acquisition. At the Yunnan Jianfeng middle-level cadre meeting held on the afternoon of the 16th, Jiang Xiaomeng first fully affirmed Yunnan Jianfeng's highest output and best benefits since it was put into production in 2018, and expressed his gratitude to all cadres and employees of Yunnan Jianfeng for their hard work. After that, Jiang Xiaomeng made a detailed analysis of the cement industry and the regional market environment in Yunnan, and combined with the current production and operation situation of Yunnan Jianfeng, put forward the focus of the next step: 1. should fully attach importance to and mobilize the initiative and responsibility of employees at all levels to improve the overall execution of the team; 2. raw material mines are an important factor restricting the future development of cement enterprises, which should be paid full attention to and formulate clear strategies and methods, set out a timetable to obtain future production resources as much as possible; 3. continuously advocate and promote technological innovation, keep pace with the times, continuously improve production management, equipment management, production technology level, and maintain the competitive advantage of the industry; 4. further strengthen production
2020
07-31